(Q35881283)

10 August 2017

Safety and tolerability of zoster vaccine in adults ≥60 years old. (English)

1 reference

10 August 2017

Alexander V Murray

1

1 reference

10 August 2017

Keith S Reisinger

2

1 reference

10 August 2017

Boris Kerzner

3

1 reference

10 August 2017

Jon E Stek

4

1 reference

10 August 2017

Timothy A Sausser

5

1 reference

10 August 2017

Jin Xu

6

1 reference

10 August 2017

William W Wang

7

1 reference

10 August 2017

Ivan S F Chan

8

1 reference

10 August 2017

Paula W Annunziato

9

1 reference

10 August 2017

Janie Parrino

10

1 reference

10 August 2017

1 November 2011

1 reference

10 August 2017

1 reference

10 August 2017

7

1 reference

10 August 2017

11

1 reference

10 August 2017

1130-1136

1 reference

The impact of herpes zoster and post-herpetic neuralgia on quality-of-life

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323493

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323493

A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323493

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323493

Comparative analysis of two rates

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323493

Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323493

Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3323493

Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older

24 September 2018

1 reference

12 December 2020

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial

1 reference

12 December 2020

Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old

1 reference

12 December 2020

Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.7.11.17982

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

22048110

1 reference